文献速递前列腺癌

大型整合医疗系统中前列腺特异性抗原筛查与转诊泌尿外科的种族差异:回顾性队列研究

Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study.
PubMed 文献 · J Urol · 2021-04-01

该回顾性队列研究纳入Atrium Health 2014–2019年门诊≥40岁男性606,985人(其中黑人87,189人),发现所有年龄和种族组PSA检测均显著下降,总体相对降幅56%。黑人男性较白人男性更可能接受PSA检测(校正OR 1.24,95%CI 1.22–1.26)和因前列腺癌转诊泌尿外科(校正OR 1.94,95%CI 1.75–2.16)。

要点

  • 2014–2019年所有年龄和种族组PSA检测均显著下降,总体相对降幅56%。
  • 黑人男性PSA检测几率高于白人男性(校正OR 1.24,95%CI 1.22–1.26)。
  • 黑人男性因前列腺癌转诊泌尿外科几率高于白人男性(校正OR 1.94,95%CI 1.75–2.16)。

核心结论

  • 2014–2019年间前列腺癌筛查持续显著下降。
  • 黑人男性PSA检测和转诊泌尿外科的几率均高于白人男性,但考虑接受PSA检测者更可能被转诊,黑人男性相对筛查不足。

研究设计与样本

  • 回顾性队列研究,使用Atrium Health企业数据仓库数据,覆盖北卡罗来纳、南卡罗来纳和佐治亚州900余个医疗点。
  • 纳入2014–2019年门诊≥40岁男性606,985人,其中黑人男性87,189人。
  • 收集年龄和种族等临床与人口学数据,仅报告人群占比>2%的种族组结局。
  • 组间比较采用卡方分析、Wilcoxon秩和检验和多变量logistic回归,显著性定义为p<0.05。

主要发现

  • 所有年龄和种族组PSA检测均显著下降,总体相对降幅56%。
  • 黑人男性较白人男性更可能接受PSA检测(校正OR 1.24,95%CI 1.22–1.26)。
  • 黑人男性较白人男性更可能因前列腺癌转诊泌尿外科(校正OR 1.94,95%CI 1.75–2.16)。

临床怎么用

  • 临床应关注2014–2019年间PSA筛查持续下降的趋势。
  • 接受PSA筛查者更可能被初级保健转诊泌尿外科进一步诊断评估,黑人男性相对筛查不足需关注。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Contemporary trends and racial disparities in prostate cancer screening and referral to urology for prostate cancer risk are not well characterized, despite consensus that Black men are at higher risk for poor prostate cancer outcomes. The objective of this study was to characterize current racial disparities in prostate cancer screening and referral from primary care to urology for prostate cancer concern within our large, integrated health care system. MATERIALS AND METHODS: This retrospective cohort study used data from Atrium Health's enterprise data warehouse, which includes patient information from more than 900 care locations across North Carolina, South Carolina and Georgia. We included all men seen in the ambulatory or outpatient setting between 2014 and 2019 who were ≥40 years old. Clinical and demographic data were collected for all men, including age and race. Racial outcomes were reported for all groups with >2% representation in the population. Between-group comparisons were determined using chi-squared analysis, Wilcoxon rank sum testing and multivariable logistic regression, with significance defined as p <0.05. RESULTS: We observed a significant decrease in prostate specific antigen testing across all age and racial groups in a cohort of 606,985 men at Atrium Health, including 87,189 Black men, with an overall relative decline of 56%. As compared to White men, Black men were more likely to undergo prostate specific antigen testing (adjusted OR 1.24, 95% CI 1.22-1.26) and be referred to urology for prostate cancer (adjusted OR 1.94, 95% CI 1.75-2.16). CONCLUSIONS: There was a continued significant decline in prostate cancer screening between 2014 and 2019. Despite having modestly elevated odds of being screened for prostate cancer compared to White men, Black men are relatively underscreened when considering that those who undergo prostate specific antigen screening are more likely to be referred by primary care to urology for additional prostate cancer diagnostic evaluation.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Lu CD, Adeyemi O, Anderson WE, et al. Racial Disparities in Prostate Specific Antigen Screening and Referral to Urology in a Large, Integrated Health Care System: A Retrospective Cohort Study. J Urol. 2021. PMID: 33793294. doi:10.1097/JU.0000000000001763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。